Interv Akut Kardiol. 2016;15(1):26-32 | DOI: 10.36290/kar.2016.005
Significant mitral regurgitation (MR) is a severe disease affecting around 10 % of people above the age of 75 years, and/or with
left ventricular dysfunction, often associated with severe symptoms of heart failure and reduced survival. While surgery remains
the treatment method of choice in low-risk patients with degenerative type of disease, in high-risk patients with functional MR
transcatheter procedure with the MitraClip System is emerging as a safe and effective alternative therapeutic option. Besides this,
several devices, addressing many different anatomical structures of the mitral valve, are under development.
Published: February 1, 2016 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...